1/2 The Immunity by Design: In Vivo Immune Cell Engineering Conference will have a dedicated @scilifelab.se session with Tina Catela Ivkovic (Center for Translational Genomics), Mikael Mattsson (Drug Discovery and Development), and Anahita Bakochi (BioMS).

1/2 The Immunity by Design: In Vivo Immune Cell Engineering Conference introduces Session 1: Cell Engineering & Reprogramming. The Pereira lab will share the stage with Judit Svensson Arvelund and Özcan Met to discuss emerging approaches in immune cell engineering and cancer immunotherapy.

1/2 We’re thrilled to announce Adi Barzel (Tel Aviv University) as a keynote speaker for Immunity by Design: In Vivo Immune Cell Engineering Conference! His work explores in vivo genome editing and strategies to engineer T and B cells for therapeutic applications.

1/2 We’re excited to announce our first keynote speaker for Immunity by Design: In Vivo Immune Cell Engineering Conference! Sai Reddy (ETH Zurich) works on engineering the immunogenome & reprogramming immune cells for applications in biotechnology, vaccination & immunotherapy.

1/2 Registration is OPEN for the Immunity by Design: In Vivo Immune Cell Engineering Conference!✨ Join us in Lund 22–23 Oct 2026 in a vibrant environment that brings together researchers from all career stages. #ImmuneEngineering #Immunotherapy #BiotechIndustry

Last chance to apply for the DDLS PhD student positions! 🚨 Deadline is today. Don’t miss the opportunity! #PhD #DDLS

1/4 Our new protocol paper is out in STAR Protocols!🎉✨ We outline how to identify transcription factor (TFs) networks for immune cell reprogramming. Read full paper here: www.cell.com/star-protoco...

1/2 If you didn’t have an exciting scientific event planned for the Fall, you do now! We are thrilled to announce the Immunity by Design: In VivoImmune Cell Engineering Conference, taking place in Lund 22-23 October 2026. #ImmuneEngineering #Immunotherapy #BiotechIndustry

🔬 Lund University (@lund-university.bsky.social) is hiring 3 Assistant Professors in cancer immunotherapy, immunotechnology & immune cell engineering! ✅ Start-up package | tenure track | world-class infrastructure 📅 Deadlines: 26 May & 10 June 2026 🎥 youtu.be/z-PQU9qknZc Apply links 👇

1/1 We are recruiting an Assistant Professor in Immuno-oncology and Immune Cell Engineering to join the newly established Division of Immuno-Oncology at Lund University! @lund-university.bsky.social

1/4 We are recruiting! Our lab was awarded a PhD grant from @scilifelab.se Data-driven Life Science (DDLS) Research School for the project “A virtual cellular reprogramming screening platform”. #DataDrivenLifeScience #CellReprogramming

1/3 Huge congrats to our team member Sandhya Malla @sa2430ma.bsky.social, who was awarded a Postdoctoral Fellowship by #Cancerfonden with her project “Decoding The Regulatory Grammar of Transcription Factor-Mediated Immune Reprogramming”!

1/2 Our PhD student Abigail Altman was one of three winners for Best Poster at the 2026 DGfI-Spring School on Immunology (@dgfi-org.bsky.social) held in the village of Ettal. She presented an outstanding poster: Programming Dendritic Cell Diversity with Direct Cell Reprogramming for Immunotherapy.

It was a great pleasure to speak two weeks ago at the Annual Meeting of the Portuguese Society of Immunology in Coimbra! #SPI #Immunology #CancerImmunotherapy

1/2 New PhD students, new ideas, new science! Excited to see what we’ll build and discover together. Welcome to the lab!✨ Find out more: pereiralab.com

Currently on the slopes of Keystone, Colorado attending the for the Symposium Myeloid Cells: Functional Heterogeneity with Therapeutic Promise. It has been a fantastic meeting so far; inspiring science, great discussions on the slopes, and exciting new perspectives on myeloid cells.

Excited to welcome our new postdocs to the lab! Looking forward to exciting science, collaborations, and discoveries together. Welcome aboard!✨ Read more about them on our website: pereiralab.com

We are happy to announce that Ervin Ascic was awarded the Best Cancer Thesis of 2025 at Lund University!

We’re excited to share that our recent paper, “A combinatorial transcription factor screening platform for immune cell reprogramming”, has been selected for the cover of the January issue of Cell Systems!✨

New from @cellreprolab.bsky.social! The REPROcode library is a collection of over 400 immune-related human transcription factors in barcoded lenti vectors. Explore the set and find your favorite or mix-and-match: www.addgene.org/browse/artic...

📢 New study from out lab published in @CellSystemsCP: REPROcode — a combinatorial single-cell screening platform to discover the transcription-factor (TF) recipes that reprogram immune cells. Read it here: www.sciencedirect.com/science/arti...

1/3 It’s an honor to share that our lab was awarded a Discovery grant from the American Brain Tumor Association (ABTA) for the project “In vivo Dendritic Cell Reprogramming as a New Immunotherapy for Glioblastoma”. @theabta.bsky.social

1/4 Great to share that our lab was awarded a research grant from the Mats Paulsson Foundation for Research, Innovation and Societal Development for the project “Advancing Reactive Tumor-Infiltrating Lymphocyte Therapy with Cellular Reprogramming”.

1/2 Sharing exciting news! ✨ Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity! @cp-immunity.bsky.social

1/3 Congrats to our team member @Peng Wei, who was awarded a SciLifeLab PULSE Postdoctoral Fellowship for his project SMARD, which will develop small molecule (SM)-assisted reprogramming to type 1 conventional dendritic cells (cDC1)! For more info see: pereiralab.com/lab-news/pen...

1/2 Celebrating a double win!✨ Yesterday, at the Lund Stem Cell Center (LSCC) retreat, Ervin Ascic was awarded the Article of the Year Award with our Science paper "In vivo dendritic cell reprogramming for cancer immunotherapy" (www.science.org/doi/10.1126/...)

1/3 Call for Authors! We are currently editing a volume on Cellular Reprogramming for Immunotherapy for the Methods in Molecular Biology series (Springer Nature). This volume will steer the future of the field and is a great way to share your lab’s protocols!

We are proud to announce that Ervin Ascic successfully defended his PhD yesterday – with the special honor of Nobel Laureate James Allison as opponent! ✨ Ervin’s work makes a strong contribution, showing that in vivo dendritic cell reprogramming is paving the way toward the clinic.

📢 New in @ImmunityCP: We have mapped the transcription factor “routes” that program two dendritic cell subsets opening paths for personalized #cancer #immunotherapy. Read it here: doi.org/10.1016/j.im... Here is a summary of what we discovered 🧵: Illustration by @azuravesta.bsky.social

1/6 Congrats to Margarida Brás and Daniel Oliveira that were awarded with PhD studentships from the Foundation for Science and Technology (FCT).

1/3 Our most recent protocol paper, “Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells”, is out in JoVE! @JoVEJournal

Doubly proud! 🎉 @inesncaiado and @luisfholiveira defended their PhDs this month with a big audience of cell reprogrammers. They brilliantly discussed their great contributions to the future of the field.

1/3 Glad to share that the work of our Postdoctoral Fellow Sandhya Malla @mal71056 secured funding from the Hanseatic Life Science Research Infrastructure Consortium (HALRIC) to study the mechanisms of dendritic cell reprogramming!

1/3 Congrats to our team member Hugo Couto Moreira, who was awarded a Doctoral INPhINIT Retaining Fellowship from “la Caixa” Foundation to develop his PhD project “Reprogramming Regulatory T-cells”! @FundlaCaixa

It’s an honor to share that our lab was awarded a Clinic & Laboratory Integration Program (CLIP) grant from the Cancer Research Institute (CRI) for the project “Engineering Synthetic Tertiary Lymphoid Structures in Melanoma with Dendritic Cell Reprogramming”. @CancerResearch

1/2 The interview series "Reprogramming Stars" featured in Cellular Reprogramming, highlights the work of leaders in the field by introducing them and their science in exciting talks. @CellRepJrnl

1/2 Congrats to our PhD student @ervin_ascic for winning the best poster award in “Improving Immunity” at the 22nd #CIMT Annual Meeting, Europe's Cancer Immunotherapy Meeting, held this year in Mainz, Germany. His work was regarded as an interesting, state-of-the-art technology.

1/3 We are excited to announce that the project Repro-TIL, standing for “Breakthrough Neoantigen-specific Tumor-Infiltrating Lymphocyte Therapies Through Novel Dendritic Cell Reprogramming”, was awarded a EIC Transition grant! @EUeic

I am excited to share that I will presenting the latest advances in in vivo reprogramming for cancer immunotherapy at the Science Spotlight session during the #ISSCR2025 Annual Meeting in Hong Kong, June 11-14, 2025.

1/4 Celebrating our collaborative efforts, highlighted in the paper “RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen presenting cells”, recently published in @PNASNews.

We recently had a great get-together joining the Pereira Lab and @AsgardThx, in an Interaction Day where all members shared their paths and aspirations. What a magnificent way to share a day with our teammates! ✨

1/3 Congrats to our team member Camille Chatelain who was awarded a Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowship. Her project will advance a strategy for cancer therapy with tumor-reactive T cells! @MSCActions

1/2 I am proud to announce that I will join the SciLifeLab community as a Group Leader! @scilifelab is a health and environmental infrastructure that fosters a solid web of researchers collaborating within sectors such as industry and health care. Read 👇

🌟Amazing full day of great discussions, 1-year progress updates & future planning as our @Eueic pathfinder #RESYNC consortium gathered in Turin. Exciting innovations ahead as we push the boundaries of chemical reprogramming! #HorizonEurope Read more:

1/3💡If you are looking for a postdoc position in transformative translational research, join our team! We are looking for a motivated postdoc to work on RNA-mediated in vivo reprogramming of cancer cells into dendritic cells.

Excited to welcome our new postdocs to the lab! 🎉 Looking forward to exciting science, collaborations, and discoveries together. Camille Chatelain, Peng Wei, Sandhya Malla (@mal71056), Inês Lopes (@inesrlopes13) and Sandra Schwarz. Welcome aboard! 🚀

1/4 Kicking off 2025 with our most recent review paper “Transcription factor-mediated reprogramming to antigen-presenting cells”, first-authored by our brilliant @lunduniversity PhD student, @ervin_ascic.

1/2 Thrilled to share that I’ve received the Emerging Alumni Award 2025 from Imperial College London, where I earned my PhD in 2009! This award celebrates leadership, societal impact, and a pioneering spirit. /FP

To close out 2024, we completed the Portuguese Coastal Camino to Santiago de Compostela—180 km of cycling. What a ride! Wishing everyone a 2025 filled with beautiful finish lines! /FP

Our PhD student @luisfholiveira won the Forskar Grand Prix! Luís’s creativity persuaded both jury and audience. He skillfully communicated the potential of hacking the code of dendritic cells to produce versatile soldiers in a war against cancer. Congrats!